Current updates on generations, approvals, and clinical trials of CAR T-cell therapy

• Главные авторы: Tadesse Asmamaw Dejenie (Автор), Markeshaw Tiruneh G/Medhin (Автор), Gashaw Dessie Terefe (Автор), Fitalew Tadele Admasu (Автор), Wondwossen Wale Tesega (Автор), Endeshaw Chekol Abebe (Автор)
• Формат: ‌
• Опубликовано: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Chimeric antigen receptor (CAR) T-cell therapy is a novel, customized immunotherapy that is considered a 'living' and self-replicating drug to treat cancer, sometimes resulting in a complete cure. CAR T-cells are manufactured through genetic engineering of T-cells by equipping them with CA...